Related Experiment Video
Updated: Jul 13, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[The diabetic patient at altitude: pathophysiology and practical implications]
S Thalmann1, B Gojanovic, F R Jornayvaz
1Service de Diabétologie, Endocrinologie et Nutrition, HUG, Genève. sebastien.thalmann@hcuge.ch
Revue Medicale Suisse
|July 21, 2007
Summary
Diabetics can travel to moderate altitudes, but high altitudes pose challenges like hypoxia and altitude sickness. Proper preparation and fitness allow diabetics to safely enjoy mountaineering adventures.
Area of Science:
- Altitude medicine
- Diabetology
- Travel medicine
Context:
- Increasing prevalence of diabetes mellitus.
- Growing trend of recreational travel to high-altitude regions.
- Potential health risks for diabetic individuals at altitude.
Purpose:
- To review the challenges and considerations for diabetic individuals traveling to moderate and high altitudes.
- To provide guidance on managing diabetes in high-altitude environments.
- To assess the safety and feasibility of mountaineering for diabetics.
Summary:
- Moderate altitudes (1500-2000m) are generally well-tolerated by diabetics, with risks including hypoxia, equipment failure, and acute mountain sickness mimicking hypoglycemia.
- High altitudes (>2500m) present greater challenges: freezing temperatures, remoteness, anorexia due to hypoxia, medication side effects, and increased incidence of mountain sickness complicate diabetes management.
- Well-informed, prepared, and fit diabetic patients with adequate equipment can successfully manage diabetes and enjoy mountaineering.
Impact:
- Highlights the need for specialized medical advice for diabetics planning high-altitude travel.
- Informs strategies for preventing and managing altitude-related complications in diabetic travelers.
- Empowers diabetic individuals to safely pursue recreational activities at altitude.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...